Bethany Brown: There Is A Need for A Validated Replacement for The Discontinued 2,3-DPG Assay
Bethany Brown, Senior Director of Transfusion Innovation and Product Development at American Red Cross, reposted from ISBT on LinkedIn about a recent article she and her colleagues co-authored, adding:
”This paper discusses the need for a validated replacement for the discontinued 2,3-DPG assay.
It also demonstrates that neither p50 or ATP reliably predict red blood cell in vivo performance, highlighting the gap in tools for fully assessing the quality of emerging red blood cell products.”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”New in Vox Sanguinis: A BEST Collaborative study reviews red blood cell (RBC) quality assessment methods.
Findings highlight:
- 2,3-DPG and P50 are not consistently correlated.
- In vitro markers like ATP provide functional insight but show weak links to in vivo RBC kinetics.
- A validated 2,3-DPG assay is essential for advancing blood product research and development.”
Title: Assessing red blood cell product quality with 2,3-DPG, ATP and p50 assays: A BEST Collaborative study
Authors: Tamar P. Feldman, Mackenzie Brandon-Coatham, Jayme Kurach, Carly Olafson, Jason Acker, Michael Wellington, Bethany L. Brown
Read the Full Article on Vox Sanguinis
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 25, 2026, 12:20Register for A Webinar on von Willebrand Disease in Ageing – EHC
-
Feb 25, 2026, 12:09Ellis Neufeld is Appointed as New Associate Editor of Blood
-
Feb 25, 2026, 12:02WFH Continues to Advance More Precise and Sustainable Care for People with Bleeding Disorders
-
Feb 25, 2026, 09:14Nominations are Open for 2027 Committee and Leadership Positions – ASH
-
Feb 25, 2026, 09:08Bastu Odoka: Closing the Gap on Anti-D Prophylaxis in Maternal Care
-
Feb 25, 2026, 08:53Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
-
Feb 25, 2026, 08:40Matthew Flick։ A Great Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium